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Summary
Mutations are typically perceived as random, independent events. We describe here non-random
clustered mutations in yeast and in human cancers. Genome sequencing of yeast grown under
chronic alkylation damage identified mutation clusters that extend up to 200 kb. A predominance
of “strand-coordinated” changes of either cytosines or guanines in the same strand, mutation
patterns and genetic controls indicated that simultaneous mutations were generated by base
alkylation in abnormally long single-strand (ss)DNA formed at double-strand breaks (DSBs) and
replication forks. Significantly, we found mutation clusters with analogous features in sequenced
human cancers. Strand-coordinated clusters of mutated cytosines or guanines often resided near
chromosome rearrangement breakpoints and were highly enriched with a motif targeted by
APOBEC family cytosine-deaminases, which strongly prefer ssDNA. These data indicate that
hyper-mutation via multiple simultaneous changes in randomly formed ssDNA is a general
phenomenon that may be an important mechanism producing rapid genetic variation.
Introduction
Mutations drive disease and evolution. Along with frequency, location and timing are key
parameters that define the biological outcomes of mutations. However, little is known about
mechanisms that govern mutation distribution across the genome and across generations,
especially those that would produce multiple simultaneous changes. While most mutations
appear to be independent and distribute randomly, studies of mutations in mouse and human
cells as well as tumor samples indicate that multiple mutations within genes can occur more
frequently than predicted by chance (Drake, 2007 and refs within). This suggests that a
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portion of mutational events, up to 1% of the total, are non-random and could be
chronologically linked (Wang et al., 2007). How these “mutation clusters” form is unclear,
but acquisition of mutations within a single or few cell generations could enhance
evolvability. As most mutations are neutral or deleterious, the production of multiple
mutations in a locus increases the chances of inactivating a specific gene, but also allows for
compensatory changes that can provide a selective advantage (Camps et al., 2007 and refs
within). Furthermore, clustered mutations allow locally high mutation densities without
overloading the rest of the genome, thereby reducing the chance of deleterious mutations
that could obscure an advantageous change.
A proof of principle for the effectiveness of multiple, closely-timed mutations comes from
somatic hyper-mutation (SHM) in activated B-cells. Following re-arrangement of the
antigen receptor loci, lymphocytes express Activation Induced Cytosine Deaminase (AID)
(reviewed in (Di Noia and Neuberger, 2007)). This protein deaminates cytosines to uracils
primarily within immunoglobulin loci, directly causing C to T transitions or driving Pol eta-
dependent mis-incorporations. Together, these result in multiple mutations clustered within
the variable region of the antigen receptor. Subsequent selection allows expansion of cells
containing variable domains with high antigen affinity. Beyond the specific example of
SHM, studies of protein evolution (reviewed in (Camps et al., 2007)), as well as recent
findings with regulatory sequences (Frankel et al., 2011)have shown that evolution often
utilizes mutations that individually are neutral or even deleterious, but when combined cause
a significant phenotypic change. Such multiple changes by random mutagenesis are highly
improbable and in cases where “fitness valleys” must be overcome, either a duplication
event followed by successive mutations, or linked, simultaneous changes are required (see
(Smith, 1970)).
Here, we describe simultaneous induction of large numbers of clustered mutations and
dissect the mechanisms that lead to their formation in yeast genomes and in human tumors.
Mutation distributions and spectra, as well as genetic controls, implied that clustered
mutations in yeast arose simultaneously through error-prone restoration of persistent ssDNA
formed at DSBs or replication forks. Analysis of human cancer datasets also revealed
clusters of mutations with characteristics strongly suggesting that their formation involves
ssDNA. Moreover, many clusters, as well as a significant fraction of total mutations in
cancers, carried a distinct mutation signature similar to those of APOBEC (apolipoprotein B
mRNA-editing enzyme catalytic polypeptide-like) cytosine deaminases.
Results
DNA damage induces clustered mutations
We hypothesized that mechanisms exist which can lead to the formation of mutation clusters
at frequencies detectable in moderately sized mitotic populations. Therefore, we designed a
strain of the yeast, Saccharomyces cerevisiae, that enabled selection of 2 or more closely
spaced mutations induced by exposure to a DNA damaging agent. Specifically, we moved
the URA3 and CAN1 coding sequences and endogenous promoters from their normal,
widely separated positions in chromosome V to adjacent positions within the LYS2 gene on
chromosome II (Figure 1). This chromosomal location allows the selection of events where
URA3 and CAN1 are inactivated by multiple point mutations but not by gross chromosomal
rearrangements (Chen and Kolodner, 1999), because the latter would eliminate surrounding
essential genes. We reasoned that mutation clusters could originate from multiple unrepaired
lesions in either double stranded (ds) or ssDNA. Regions around DSBs are prone to
spontaneous mutation (Hicks et al., 2010; Ponder et al., 2005; Strathern et al., 1995; Yang et
al., 2008), and when these regions are manipulated to be artificially long-lived, they can
accumulate ssDNA with multiple DNA damages that each lead to a mutation (Burch et al.,
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2011; Yang et al., 2010; Yang et al., 2008). Clusters originating from lesions in dsDNA
would invoke strong local inhibition of DNA repair by a yet unknown mechanism (See
Discussion). To discriminate between ssDNA and dsDNA sources of clusters, we induced
mutations by chronic, low dose exposure to methyl-methanesulfonate (MMS). This mutagen
has a diagnostic ssDNA mutation signature (Yang et al., 2010) but also induces mutations
through damage to dsDNA.
Both haploid and diploid versions of the URA3-CAN1 reporter strains were grown on rich
media containing non-lethal concentrations of MMS (Table S1) for approximately 25
generations to induce DNA alkylation and mutations. Growth in the presence of MMS
greatly elevated the frequencies of cells resistant to the drugs 5-FOA and canavanine (CAN)
individually (ura3 and can1 selection, respectively; Table S2) as well as the frequency of
isolates resistant to both drugs (referred to as FOA-CAN resistant; Figure 2A). Exposure of
wild type haploid yeast carrying adjacent URA3-CAN1 genes to 2 mM and 4 mM MMS
increased the estimated frequencies FOA-CAN resistance to 1.4 and 7.9 colonies/plate,
respectively, over a background of 0.15 resistant colonies/plate resulting from spontaneous
deletion of the reporter. After correcting for the Loss of Heterozygosity (LOH) (Table S2)
required for expression of recessive phenotypes, the estimated frequency of mutations
conferring FOA-CAN resistance for diploid versions of these strains treated with 4 mM
MMS appeared even higher than that for similarly treated haploid cells, ranging from 57 to
91 resistant colonies/plate. In all cases, the frequency of dually resistant isolates from the
adjacent URA3-CAN1 strains was much higher than expected from the accumulation of
independent ura3 and can1 mutations as measured by FOA-CAN dual resistance of
separated URA3-CAN1 strains (compare Adj and Sep in Figure 2A; Table S2). This
suggested an association of the mutational events.
Sanger sequencing of the URA3, CAN1, and LYS2 regions suggested mutation clusters may
be large because the data contained an unusually high frequency of mutations in excess of
the 2 minimally required for resistance (20% of sequenced clones treated with 2 mM and
50% treated with 4 mM; Table S3A). We therefore investigated the appearance of mutations
throughout the genomes of selected isolates. Sixty-nine yeast clones were sequenced, chosen
from 4 genotypes, 2 MMS concentrations, and 3 selection methods (i.e., unselected, 5-FOA
selected, and FOA-CAN selected). As shown in Table S4A, 59–78% mutations occurred
within genes, comparable to the percentage of the genome that is protein coding. Base pair
substitutions accounted for 90% of all mutations; 7% were small insertions or deletions
(termed Indels) and 3% were categorized as “complex,” consisting of 2 or more mutations
with each separated by less than 10 bp from their nearest neighbor. Since complex mutations
likely originate from trans-lesion synthesis past a single DNA lesion (Harfe and Jinks-
Robertson, 2000), they were treated as a single event.
The median genome-wide mutation density in MMS treated yeast was low, at 12 mutations
per haploid genome or ~1 mutation/Mb (Table S4). To address the possibility of clustering,
we identified groups of mutations in which each mutation was no further than 100 kb from
the next (chosen to be a 10 fold higher mutation density than genome-wide) and calculated
the likelihood of observing the mutation distribution assuming all the mutations in the
genome were independent and random. Groups of mutations with P-values <0.01 were
classified as mutation clusters. Using this analysis, all ura3 and can1 mutations selected by
FOA-CAN resistance comprised at least part of a mutation cluster (Table S4B).
Surprisingly, FOA-CAN selected clusters ranged from 2 to a remarkable 30 mutations
spanning more than 150 kb (Figure 2C and D, Table S4C, Figure S1). Importantly, the
remaining 99% of the genome was relatively devoid of mutations (containing 1 to 52
mutations) (Table S4B, e.g., Figure 2B). P-values of FOA-CAN selected clusters ranged
between 10−2 and 10−57 with P<10−5 for 55% of clusters (Figure 2E). Clusters were
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generally longer in diploid yeast than in haploid (Figure 2C), with all FOA-CAN selected
clusters greater than 100 kB in length originating from diploid strains. This apparent impact
of ploidy on cluster size, however, may be at least partly due to inhibition of non-
homologous end-joining (NHEJ) in the a/alpha mating type (Valencia-Burton et al., 2006)
and refs within), as NHEJ can compete with DSB end resection (see below). Indeed, no
statistical difference in cluster size was observed when comparing diploids with
homozygous mating types (clusters from alpha/alpha and a/a mating types combined) to
similarly treated haploids (P=0.205 for length and P=0.36 for number of mutations
comparing yeast treated with 4 mM MMS; Figure 2C and D). In addition to clusters
containing mutations in URA3 and CAN1, we also identified 25 unselected clusters among
17 isolates with P-values ranging between 1.72X10−8 and 9.9X10−3 (Table S4D). These
appear to be bona fide as they are not associated with subtelomeric regions (i.e., having
mutations within 30 kb of a chromosome end) or other repeat regions (Long Terminal
Repeats (LTRs) or retrotransposons) that can produce false clusters as a result of mapping
artifacts. Unselected clusters displayed characteristics similar to those selected by FOA-
CAN resistance (see below). The existence of unselected clusters indicates that while the
occurrence of FOA-CAN resistant colonies is rare, cluster formation in other areas of the
genome may be relatively frequent or that specific sub-populations may be particularly
prone to mutation clusters.
MMS-induced mutations in clusters are strand-coordinated and simultaneous
The median density of MMS-induced mutations in clusters was 1 mutation per 3 kb, over
500 fold greater than in the rest of the genome. Furthermore, the probability of observing
any individual cluster by the random coincidence of mutations was often incredibly low
(e.g., P-values = 9.4x10−57 to 3.3x10−5 for clusters with >4 mutations). This suggested that
the mutations within a cluster were not independent but instead were concerted in time and
by mechanism. Supporting the non-random incidence of mutations in clusters, the estimated
frequency of FOA-CAN resistance in the haploid strain with adjacent URA3 and CAN1
genes was 50 fold higher than when these genes were separated by 83 kb (Figure 2A, Table
S2). Additional evidence confirming the simultaneous incidence of clustered mutations (i.e.,
occurring within one generation) emerged from the analysis of the MMS-induced mutation
spectrum. While all types of mutation were present in clusters, substitutions at G:C base
pairs predominated (Figure 3, Figure S2). Strikingly, when only clustered mutations in G:C
pairs were displayed, a phenomenon that we defined as “strand-coordination” became
evident. The substitutions of G:C pairs occurred almost exclusively as long series of either
mutated cytosines or mutated guanines in the sequenced strand (Figure 4A and B). If DNA
damage and subsequent mutations were accumulated through multiple cell divisions,
mutation of cytosine (or guanine) would have the opportunity to occur on either DNA
strand. Consequently, clusters formed with non-simultaneous mutations of G:C pairs (i.e.
occurring in different cell generations) would be expected to show a random mix of
guanines and cytosines mutated in the same strand. Thus, strand-coordinated stretches of
mutations are likely generated simultaneously within a single cell cycle.
Clustered mutations arise from alkylation damage to ssDNA
We next compared the MMS-induced mutation spectra of non-clustered (termed scattered)
mutations distributed throughout the genome to that found in mutation clusters. Based on the
concentration of MMS used, scattered mutations either occurred primarily at A:T bases (2
mM MMS = 71% A:T and 29% G:C) or showed no base preference (4 mM MMS = 49%
A:T and 51% G:C). At either concentration of MMS, however, mutation clusters were
enriched in mutated G:C pairs (Figure 3 and Figure S2) despite the higher prevalence of A:T
bases in chromosome 2 (Figure S2) indicating the G:C preference was not due to the base
composition in the region of selection. This enrichment suggests the contribution of unique
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mutagenic lesions in cytosine and/or guanine within the mutation cluster spectrum. The
strand-coordination of clustered mutations requires that there be only one primary mutagenic
lesion per base pair which, in the case of G:C pairs, could be a methylated cytosine or a
methylated guanine. Based upon the known spectrum of MMS-induced alkylation (Beranek,
1990), the mutagenic capacity of MMS lesions, and our previous work describing the
mutation spectrum of MMS damaged ssDNA (Yang et al., 2010), we suggest that the
selected mutation clusters result largely from N3-methyl cytosine, a mutagenic single-strand
specific MMS lesion. Consistent with this suggestion, the mutation spectrum in clusters
showed a significant under-representation of C to G and G to C transversions (Table S4A),
as previously reported for error-prone bypass of N3-methyl cytosine lesions in E.coli
(Delaney and Essigmann, 2004). Thus, persistent ssDNA is apparently formed naturally,
likely in response to DNA damage. Once formed, these regions can accumulate ssDNA-
specific damage, presumably due the lack of repair capacity in ssDNA, ultimately resulting
in error-prone trans-lesion synthesis (TLS) during the restoration of ssDNA to dsDNA.
Clustered mutations are formed during DSB repair
The identification of ssDNA as the target for MMS-induced mutation clusters suggests
several cellular processes that may contribute to cluster formation, including resection of a
DSB during homology directed repair. Resection from a DSB occurs only in the 5′ to 3′
direction (Mimitou and Symington, 2011). Consequently, N3-methyl cytosines accumulated
in the ssDNA on opposite sides of a break would belong to opposite strands of the repaired
double helix. Since sequencing only reports one strand of a chromosome oriented in the 5′
to 3′ direction, a cluster resulting from damage to bi-directional resection of a DSB should
display mutated cytosines to the 5′ side of a DSB, while the 3′ side, which is
complementary to the damaged ssDNA stretch, should display mutated guanines (Figure
4C). The position of the switch from C-coordination to G-coordination in the sequenced
strand would indicate the approximate location of the break site. Among the 69 sequenced
genomes, 9 clusters contained strand-coordination switches (Figure 4B). Seven of these
clusters clearly demonstrated the expected pattern for N3-methyl cytosine lesions within bi-
directional resection tracts: C-coordination always on the 5′-side and G-coordination on 3′-
side. The 2 remaining switching clusters may also be associated with DSBs but appear to be
more complex events (Figure 4B, Dataset Cluster IDs 44 and 49). Thus, recombinational
DSB repair likely accounts for least 13% of the total clusters we sequenced. Interestingly,
many switching clusters spanned further than 100 kb and would require resection tracts
significantly longer than those previously estimated using direct measurements at site-
specific (Chung et al., 2010 and refs within) or radiation-induced breaks (Westmoreland et
al., 2009) in populations. Such unexpectedly long resection seems unnecessary for the repair
of most DSBs, suggesting these clusters reflect a minor category of events where
downstream steps of recombination were delayed. Remarkably, even these unusual repair
intermediates are restored without deletion despite the presence of multiple lesions in the
long stretches of ssDNA.
Dysfunctional replication forks result in mutation clusters
While long bi-directional resection of DSBs was the likely origin of large clusters with
strand-coordination switches, clusters without switching could be generated by a variety of
mechanisms producing ssDNA, one potential source being dysfunctional replication forks.
Long ssDNA regions are produced when replicative polymerases stall at lesions but the
MCM helicase continues to proceed (Lopes et al., 2006). To assess the contribution of DNA
replication in the formation of non-switching clusters, we utilized genetic defects that
exacerbate fork dysfunction. In Saccharomyces cerevisiae, deletion of TOF1, CSM3, or
MRC1 which encode components of the replication fork protection complex, increases
polymerase-helicase uncoupling during hydroxyurea treatment (Bando et al., 2009; Katou et
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al., 2003). We therefore disrupted TOF1 and CSM3 to increase the prevalence of
replication-associated ssDNA and selected for MMS-induced mutation clusters using two
versions of the deficient strains: one containing the URA3-CAN1 reporter to the left (5′) of
the ARS216 origin of replication and a second with the reporter to the right (3′) of ARS216
(Figure 1A and B, respectively). Regardless of the location of the URA3-CAN1 reporter,
disruption of either TOF1 or CSM3 increased the frequency of FOA-CAN resistant clones
3–4 fold (Figure 5B), indicating that 66 to 75% of the isolated clusters were caused by
replication fork defects. Sanger Sequencing of the URA3 and CAN1 coding regions
revealed that clusters from both the tof1Δ and csm3Δ backgrounds were strand-coordinated
(i.e., having a higher frequency of C-C and G-G mutation pairs than the C-G and G-C
mutation pairs) similar to clusters obtained from wild type strains (Table S3B). Moreover,
the strand-coordinated clones displayed “strand bias” dependent on the position of the
selective reporter relative to the origin of replication. Strand-coordinated clusters selected to
the left (5′-side) of ARS216 in the tof1Δ and csm3Δ strains were composed primarily of
mutated guanines whereas those selected to the right (3′-side) of the origin consisted almost
exclusively of mutated cytosines (Figure 5C and Table S3C). This change in bias based on
the position of the reporter confirms that the majority of strand-coordinated clusters in the
tof1Δ and csm3Δ backgrounds are associated with the replication fork and suggests that
ssDNA generated at stalled forks may be a significant contributor to cluster formation in
wild type cells. Furthermore, the specific bias observed (guanines mutated on the left (5′) of
origin and cytosines mutated to the right (3′)) implies that replication-associated ssDNA
was formed by either specific uncoupling of lagging strand synthesis, possibly the result of
increased Okazaki fragment length, or through damage of the ssDNA exposed during one-
ended recombinational repair of a collapsed fork (one of the outcomes on Figure 5) by
mechanism of break-induced replication (Llorente et al., 2008).
Clusters of strand-coordinated mutations highlight mutagenic pathways in human cancers
Do mutation clusters occur in other biological systems? To address this question, we
searched for clusters among the 210,022 mutations identified in whole-genome sequencing
of the following human malignant tumors: 23 multiple myelomas (Chapman et al., 2011), 7
prostate cancers (Berger et al., 2011), and 2 head and neck squamous cell carcinomas
(HNSCC) (Stransky et al., 2011). We looked for mutation densities and clustering P-values
similar to those of MMS-induced clusters in yeast. Specifically, we defined a cluster as 2 or
more mutations in which: (i) all immediate neighbors were separated by no more than 10 kb
and (ii) and whose cluster P-value was no greater than 10−4 (Supplemental text). To focus
on clustered mutagenesis occurring at random genomic locations, we also excluded clusters
identified in a small fraction of the genome containing known targets for AID (Table S5) as
they are likely the result of SHM (see Introduction). In non-SHM regions, we found 394
clusters scattered among all chromosomes containing 1,625 mutations and ranging in size
from 12 to 53,411 base pairs (Figure 6, Tables S6 and S7). Similar to our observations in
yeast, clusters in cancers had an overall strong strand-coordinated component. This indicated
that in the majority of clusters, most of the mutations occurred simultaneously in the same
DNA molecule (Table S7B). This conclusion allowed us to apply cluster analysis to
sequenced cancers in spite of the often heterogeneous cellular composition of tumors. As the
coincidence of mutations is even more likely for clusters composed entirely of mutations of
the same base in the sequenced strand, we classified clusters into 3 groups: A- or T-
coordinated, C- or G-coordinated, or non-coordinated for further analysis aimed at
identifying mechanisms leading to cluster formation. There were 8, 18 and 94 completely
strand-coordinated clusters in the HNSCC, prostate, and myeloma datasets respectively,
with the majority of these C- or G-coordinated (Figure S3A, Table S7C).
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Mutations in A- (or T-) coordinated clusters were enriched at a motif, WA/TW (where W is
A or T; the mutated base is underlined). This motif is identified with mutations generated by
TLS DNA polymerase eta in Ig-SHM regions (Rogozin et al., 2001). Consistent with Pol eta
introducing the mutations, A- or T-coordinated clusters were composed primarily of A to G
and T to C transitions (Table S7D), however, alternative ways of generating A- or T-
coordinated clusters exist but are not distinguished in this study.
Nearly all mutations in C- or G-coordinated clusters were in TC or GA motifs, which in turn
were strongly enriched at TCW or WGA in each type of cancer and in the total of the three
datasets (Figures 6B, 6C and S3). This motif specificity exactly matches the signature of the
RNA and DNA editing cytosine deaminases APOBEC1 (A1) (Beale et al., 2004),
APOBEC3A (A3A) (Thielen et al., 2010), APOBEC3B (A3B), APOBEC3F (A3F) (Bishop
et al., 2004) and APOBEC3H (A3H) (Henry et al., 2009) (hereafter referred to as TC-
specific APOBECs). In agreement with uracils being formed by deamination, the most
frequent substitution at cytosine was thymine, which could be due to the insertion of adenine
across from uracils or AP sites generated by uracil DNA glycosylase. Guanine was the
second-most frequent substitution at cytosine, which is also consistent with the mutation
properties of AP sites in yeast as well as mammalian TLS (Table S7D) (Gibbs et al., 2005;
Simonelli et al., 2005). Another striking feature of C- or G-coordinated clusters was that in
all three cancer datasets, they often co-localized with one or more rearrangement
breakpoints identified in those studies. In contrast, no A- or T-coordinated clusters co-
localized with breakpoints (Figures 6A and S3A, Table S7C). The specific colocalization of
C- or G-coordinated clusters with rearrangements suggests that they may be associated with
ssDNA intermediates of DNA repair processes that generate rearrangements (Chen and
Kolodner, 1999), and further strengthens our speculation about the APOBECs, which have a
strong preference for ssDNA over dsDNA (Harris and Liddament, 2004). Altogether, the
combination of strand-coordination, prominent enrichment with a motif targeted by a
physiological ssDNA-specific mutagen and co-localization with rearrangement breakpoints
strongly suggests that C- and G-strand coordinated clusters originated from ssDNA stretches
formed by abnormal DSB processing or at uncoupled replication forks, similar to the
mechanisms that we revealed in our yeast system.
Interestingly, non-coordinated clusters were also enriched in mutations at the WA/TW and
TCW/WGA motifs suggesting that this class of clusters may arise from the combined action
of the two mechanisms separately responsible for each category of coordinated clusters.
Non-coordinated clusters, similar to C- or G-coordinated clusters, were not enriched in any
other motifs analyzed (Figure 6B) (e.g., CC for APOBEC3G (Beale et al., 2004) or CpG)
including the WRC/GYW (where R is T or C and Y is A or G) motif characteristic of AID
activity (Rogozin and Kolchanov, 1992), suggesting that these clusters are not the result of
inappropriately targeted SHM.
We proposed that mechanisms that lead to clustered mutations could have contributed
significantly to the overall mutagenesis during the evolution of the sequenced tumors.
Mutations in the CpG (CG/CG) motif are usually highly enriched in tumors (Greenman et
al., 2007). Indeed, there was a statistically significant enrichment of CpGs among mutations
as compared with the presence of these motifs in the immediate neighborhood of mutated
bases (+/− 10 nt) across all of the tumors examined (Figure 7A, Figure S4, Table 8).
However, since the presence of CpG motifs in genomes is generally reduced (Swartz et al.,
1962), the fraction of mutations in CpG was usually small (Figure 7B, Figure S4, Table S8).
Importantly, we observed enrichment of the 2 motifs that dominate clustered mutations,
WA/TW and TC/GA. Similar to mutations in clusters, there was not a consistent genome-
wide enrichment of mutations at the AID motif (WRC/GYW) in all tumor samples, even
though potential genomic targets of AID were not excluded from this analysis. Mutations in
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TC/GA were enriched across all samples and comprised one of the most frequent classes of
mutations, reaching ~50% of all mutations in one tumor (Figure 7B, Table S8B).
Importantly, the enrichment with TCW or WGA, which define APOBEC A1/A3A/A3B/
A3F/A3H specificity, was higher than the enrichment with the less stringent TC/GA motif
across all cancer samples (Figure 7A, Table S8B) suggesting that these enzymes may be
responsible for a fraction of TC/GA mutations and contribute significantly to the overall
mutagenesis seen in tumors.
Discussion
Clusters of simultaneous mutations are a general phenomenon
Our results revealed the presence of mutation clusters apparently associated with long
ssDNA in two very different biological systems: yeast cells proliferating under chronic
DNA damaging conditions and in human malignant tumors, whose only similarity is the
high density of mutations accumulated over generations (0.1–2 per Mb). Once a mutagen is
present (MMS in yeast or APOBEC in cancers), the limiting factor in cluster formation
appears to be the formation of ssDNA, where the length of ssDNA region and the time it
persists are the key parameters determining the cluster’s mutation density and length.
Importantly, many DNA damaging agents, in addition to being mutagenic, can increase
formation of ssDNA by causing single and double strand breaks or fork uncoupling
(Friedberg, 2006 and refs within). Therefore, formation of ssDNA in MMS-treated yeast and
in cancers could well be associated with the same DNA damage that led to mutations. Both
MMS base damage and APOBEC cytosine deamination are handled by base excision repair
(BER) systems. DSBs could occur either through creation of an unstable backbone at AP
sites or through BER-associated breakage (Ma et al., 2008), thereby increasing the
likelihood of cluster formation. Alternatively, as generation of ssDNA is a part of many
cellular processes including transcription, DNA repair, and even the DNA damage
checkpoint, it may be formed independently of mutagenic damage. Mammals employ
safeguards against the production of ssDNA potentially to combat hyper-mutability.
Specifically for the case of end-resection, the amount of ssDNA produced in mammalian
cells is limited due to the preferential use of non-homologous end joining for repair of DSBs
(Beucher et al., 2009). Also, BRCA1 and 53BP1 control the length of ssDNA created once a
DNA end has committed to resection (Bunting et al., 2010). Since we found that human
tumors contain mutation clusters co-localizing with rearrangement breakpoints, we suggest
that the mammalian end resection machinery is capable of generating long ssDNA stretches
which are prone to mutation cluster formation. Based on our yeast results, dysfunctional
(potentially uncoupled) replication forks should also be considered as a source of ssDNA,
either continuous or in patches, that initiates mutation clusters in human cancers. Thus, it is
important to uncover the genetic defects and conditions that could lead to formation of
persistent long ssDNA during break resection and/or fork uncoupling.
A permanent record of hyper-mutation in human cancers
Our analysis revealed that mutations in C- or G-coordinated clusters in sequenced human
cancers often fell into motifs characteristic of a subgroup of APOBEC family cytosine
deaminases. These enzymes have been implicated in carcinogenesis based on their
mutagenic capacity and presence of mutations in TCW motifs among oncogenic mutations
(Beale et al., 2004). TC or TCW base substitutions are also highlighted in the lists of
mutations from several cancer samples (Stephens et al., 2005). Our findings of many
clusters composed almost entirely of strand coordinated mutations in TC(W)/(W)GA motifs
and the co-localization of these clusters with rearrangement breakpoints support a
speculation that TC(W)-specific APOBECs could have acted as potent ssDNA mutagens
during the history of some cancers. Consistent with this view, over-expression of APOBEC1
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is tumorigenic in mice (Yamanaka et al., 1995). Thus, a detailed understanding of the
regulation of the APOBECs and mechanisms limiting their access to chromosomal DNA is
important, especially in light of recent work implicating specific APOBEC family members
in active demethylation of chromosomal DNA in stem cells (Chahwan et al., 2010 and refs
within). Based on a combination of the biochemical capacity of the APOBEC enzymes to
induce simultaneous mutations in ssDNA and the mutation signatures observed in cancers,
we speculate that genome-wide mutations may occur within one cell cycle through
APOBEC activity at multiple, concurrently formed ssDNA regions such as replication forks
or at abnormally persistent transcription bubbles (Aguilera, 2002). This provides a specific
means by which the increase in mutability often ascribed to carcinogenesis (Loeb, 1991),
could operate via a transient hyper-mutability that generates multiple mutations and results
in selective growth advantage over just one or a very few cell generations.
Multiple paths to mutation clusters
We show here that the combination of strong selective pressure and chronic non-lethal DNA
damage can result in clusters of up to 30 simultaneous mutations in yeast suggesting that
localized, transient hyper-mutation is the most efficient means to produce change in this
situation. Furthermore, we discovered that several sequenced human cancers harbor clusters
with features similar to those found in yeast. While damaged ssDNA appears to be the
primary cause of mutation clusters in yeast and even in a certain significant fraction of
clusters in cancer mutation datasets, several other mechanisms and mutagenic factors likely
contribute to cluster formation depending on the biological system in which they occur. In
addition to C- or G-coordinated clusters that could be mediated by TC-specific APOBECs,
our analysis of cancer mutation data sets also uncovered A- or T-coordinated clusters which
strongly associated with the mutation motif WA/TW. This is consistent with a role of Pol eta
in the formation of these clusters; however, the high likelihood of random incidence of WA/
TW sequence does not allow discrimination among several potential mechanisms based
upon the WA/TW motif alone. Regardless of the details of A- or T-coordinated cluster
formation, the mechanism of formation is clearly distinct from those mediating C- or G-
coordinated clusters in human cancers and the MMS-induced clusters in yeast. Beyond the
systems we investigated here, we also expect mutation clusters to be prevalent in tumors that
have a known exogenous damage component as they are likely to experience the lesions
required to generate mutation clusters. DNA repair inhibition due to heterochromatin
(Livingstone-Zatchej et al., 2003), telomeric sequences (Rochette and Brash, 2010), or high
transcription (Datta and Jinks-Robertson, 1995), could also be candidate mechanisms. In
fact, future studies may show that some of these, or other unknown mechanisms, could be
responsible for clustered mutations that compose the additional portion of the MMS-induced
spectra beyond the coordinated mutations in C or G that highlight the ssDNA pathways in
the yeast clusters.
Our studies with yeast and cancer mutations suggest that simultaneous multiple changes
may actively drive disease and evolution. The production of several simultaneous mutations
within biologically functioning sequences appears to be ubiquitous and is potentially an
efficient means to produce rapid change in the face of strong selection. Additionally, the
analysis of mutation clusters within cancers as well as various other biological systems is an
effective tool for unraveling a complex “archeological record bearing the imprint of
mutagenic and DNA repair processes” (Stratton, 2011).
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Mutagenesis and selection of yeast
Yeast were grown at 30°C in 5 mL of liquid YPDA media for 2 days to stationary phase
(~2x108 cells/mL for ade5-1 strains and ~9x108 cells/mL for ADE+ strains), diluted to
1x107 cells/mL (for mutagenesis) and 2x103 cells/mL (for survival), and plated using a
multi-pronging device (Jin et al., 2003 and refs within) as 120 independent 1uL exposure
cultures on each plate of fresh YPDA containing either 0, 2 or 4 mM MMS. Densely plated
yeast was then grown for 2 days, and replica-plated to YPDA or synthetic complete media
containing either: 5-FOA, canavanine, or both drugs. Replicas on 5-FOA, canavanine, and
YPDA media were incubated for 6 days; plates with both 5-FOA and canavanine were
incubated for 7 days. Resistant colonies were counted and independent isolates (1 per
pronged culture) were sequenced. Unselected independent isolates were obtained from
cultures replica plated to YPDA media.
Estimation of diploid FOA-CAN resistance independent of Loss of Heterozygosity (LOH)
Since FOA-CAN resistance is a recessive phenotype, a cross-over and LOH event is
required to select diploid cells containing mutation clusters with the URA3-CAN1 reporter.
We determined the frequency of LOH during growth on 4 mM MMS in wild type diploid
yeast heterozygous for the URA3-CAN1 reporter and carrying a/alpha, alpha/alpha, and a/a
mating type alleles. The median LOH frequency was determined as the number of FOA-
CAN resistant cells/survivor among 6 replicates of the experiment (Table S2). To adjust
FOA-CAN resistance for LOH frequency, the mean number of FOA-CAN resistant
colonies/plate was divided by the median frequency of LOH calculated for the same
genotype.
Whole genome sequencing
Yeast containing 3 or more mutations in the LYS2::URA3-CAN1 reporter, or strand-
coordination of two single mutations in URA3 and CAN1 were whole-genome sequenced.
Genome sequencing and analysis was conducted similar to (Burch et al., 2011 and refs
within) using S288C (http://www.yeastgenome.org/) as a starting DNA sequence for
reference-based mapping and mutation calling. Yeast genomic DNA was sheared and 300 to
400 bp fragments were extracted after gel electrophoresis. Libraries were constructed and
sequenced by Illumina protocols on either an Illumina GAII or HiSeq2000 sequencer. Reads
were mapped to a reference genome (>20x average coverage) and mutations identified with
CLC Bio Genomics Workbench 4.7.2. For haploid genomes, we required all mutations to be
covered by at least 4 paired reads and exist in at least 90% of these reads. For diploid
genomes, we required coverage of 9 paired reads and presence in at least 90% of reads for
homozygous mutations and in between 45 and 55% of reads for heterozygous mutations. We
further required mutations to be unique among all samples sequenced except for those
mutations occurring in URA3 and CAN1 where bottlenecks of URA3+ and CAN1+ single
cells separated the sequenced isolates. For spectra analysis, mutations in repeat regions (i.e.,
telomeric regions, retro-transposons, and LTRs) were ignored. False positive and negative
rates of 2.2% and 2.2% respectively were estimated by comparing the mutations found in
the LYS2 reporter region, including URA3 and CAN1, by Illumina sequencing to
corresponding Sanger sequencing.
Identifying clusters
We searched for clusters among lists of genomic locations (chromosome and nucleotide
position) of mutations defined by sequencing of individual yeast or human genomes. We
first identified complex mutations defined as groups of mutations where consecutive
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mutations are less than 10 nucleotides apart, based on the estimated capacity of DNA
polymerases to make consecutive errors in a single round of synthesis (Sakamoto et al.,
2007). Each complex mutation was counted as a single event and only accounted for a small
fraction of all events. They were practically absent in clusters (Tables S4 and S6).
The following categories of mutations in human cancer datasets were excluded (filtered)
before the cluster search:
1. . All mutations that were listed in the original analyses as identical to known
dbSNPs (6.3 – 8.9% of all mutations).
2. . All mutations that fell into the simple Repeat Track
(http://genome.ucsc.edu/cgi-bin/hgTrackUi?
hgsid=204690969&c=chr8&g=simpleRepeat), a list of short and long tandem
repeats identified in the corresponding release of human genome sequence. These
mutations (5.3 – 8.5% of all mutations) were excluded because of the high chance
of false positives within low complexity sequences.
When calculating Cluster P-values, mutations excluded while assessing clustering in the
human cancer data sets were included in the total number of changes that could be randomly
distributed in the genome. This is a conservative approach that can lead only to an increase
in the calculated P-value, never to a decrease.
After any filtering, the groups of consecutive mutations, within which any pair of adjacent
mutations was separated by less than 100,000 nucleotides (for yeast) or 10,000 nucleotides
(for cancer data sets), were identified and the probability for each mutation cluster occurring
by chance (P-value) was calculated (see Supplemental Experimental Procedures).
Other Experimental Procedures
Complete experimental procedure information is provided in the Supplemental Experimental
Procedures.
Accession Numbers
Yeast S288C chromosomal DNA sequences used for Illumina read mapping and mutation
calling were taken from the Saccharomyces Genome Database
(http://www.yeastgenome.org/). Sequencing data containing human cancer mutations
analyzed in this paper were submitted at the time of original publication to the dbGaP
repository (http://www.ncbi.nlm.nih.gov/gap) under the following accession numbers:
multiple myelomas (Chapman et al., 2011) - phs000348.v1.p1; prostate carcinomas (Berger
et al., 2011) - phs000330.v1.p1; head and neck squamous cell carcinomas (Stransky et al.,
2011) - phs000370.v1.p1.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We would like to thank Drs. Tom Kunkel, Paul Wade, Kin Chan, and Scott Lujan for critical reading of the
manuscript and advice. This work was supported by the Intramural Research Program of the NIEHS (NIH, DHHS)
project ES065073 to M.A.R., by NIH Grant RC1 ES018091-02 and UNC University Cancer Research Fund to
P.A.M, and by NIEHS/NIH Contract GS-23F-9806H and Order: HHSN273201000086U to R.S.
Roberts et al. Page 11














Aguilera A. The connection between transcription and genomic instability. Embo J. 2002; 21:195–201.
[PubMed: 11823412]
Bando M, Katou Y, Komata M, Tanaka H, Itoh T, Sutani T, Shirahige K. Csm3, Tof1, and Mrc1 form
a heterotrimeric mediator complex that associates with DNA replication forks. J Biol Chem. 2009;
284:34355–34365. [PubMed: 19819872]
Beale RC, Petersen-Mahrt SK, Watt IN, Harris RS, Rada C, Neuberger MS. Comparison of the
differential context-dependence of DNA deamination by APOBEC enzymes: correlation with
mutation spectra in vivo. J Mol Biol. 2004; 337:585–596. [PubMed: 15019779]
Beranek DT. Distribution of methyl and ethyl adducts following alkylation with monofunctional
alkylating agents. Mutat Res. 1990; 231:11–30. [PubMed: 2195323]
Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Sivachenko AY, Sboner A, Esgueva
R, Pflueger D, Sougnez C, et al. The genomic complexity of primary human prostate cancer.
Nature. 2011; 470:214–220. [PubMed: 21307934]
Beucher A, Birraux J, Tchouandong L, Barton O, Shibata A, Conrad S, Goodarzi AA, Krempler A,
Jeggo PA, Lobrich M. ATM and Artemis promote homologous recombination of radiation-induced
DNA double-strand breaks in G2. Embo J. 2009; 28:3413–3427. [PubMed: 19779458]
Bishop KN, Holmes RK, Sheehy AM, Davidson NO, Cho SJ, Malim MH. Cytidine deamination of
retroviral DNA by diverse APOBEC proteins. Curr Biol. 2004; 14:1392–1396. [PubMed:
15296758]
Bunting SF, Callen E, Wong N, Chen HT, Polato F, Gunn A, Bothmer A, Feldhahn N, Fernandez-
Capetillo O, Cao L, et al. 53BP1 inhibits homologous recombination in Brca1-deficient cells by
blocking resection of DNA breaks. Cell. 2010; 141:243–254. [PubMed: 20362325]
Burch LH, Yang Y, Sterling JF, Roberts SA, Chao FG, Xu H, Zhang L, Walsh J, Resnick MA,
Mieczkowski PA, et al. Damage-induced localized hypermutability. Cell Cycle. 2011; 10:1073–
1085. [PubMed: 21406975]
Camps M, Herman A, Loh E, Loeb LA. Genetic constraints on protein evolution. Crit Rev Biochem
Mol Biol. 2007; 42:313–326. [PubMed: 17917869]
Chahwan R, Wontakal SN, Roa S. Crosstalk between genetic and epigenetic information through
cytosine deamination. Trends Genet. 2010; 26:443–448. [PubMed: 20800313]
Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, Schinzel AC, Harview CL, Brunet
JP, Ahmann GJ, Adli M, et al. Initial genome sequencing and analysis of multiple myeloma.
Nature. 2011; 471:467–472. [PubMed: 21430775]
Chen C, Kolodner RD. Gross chromosomal rearrangements in Saccharomyces cerevisiae replication
and recombination defective mutants. Nat Genet. 1999; 23:81–85. [PubMed: 10471504]
Chung WH, Zhu Z, Papusha A, Malkova A, Ira G. Defective resection at DNA double-strand breaks
leads to de novo telomere formation and enhances gene targeting. PLoS Genet. 2010; 6:e1000948.
[PubMed: 20485519]
Datta A, Jinks-Robertson S. Association of increased spontaneous mutation rates with high levels of
transcription in yeast. Science. 1995; 268:1616–1619. [PubMed: 7777859]
Delaney JC, Essigmann JM. Mutagenesis, genotoxicity, and repair of 1-methyladenine, 3-
alkylcytosines, 1-methylguanine, and 3-methylthymine in alkB Escherichia coli. Proc Natl Acad
Sci U S A. 2004; 101:14051–14056. [PubMed: 15381779]
Di Noia JM, Neuberger MS. Molecular mechanisms of antibody somatic hypermutation. Annu Rev
Biochem. 2007; 76:1–22. [PubMed: 17328676]
Drake JW. Too many mutants with multiple mutations. Crit Rev Biochem Mol Biol. 2007; 42:247–
258. [PubMed: 17687667]
Frankel N, Erezyilmaz DF, McGregor AP, Wang S, Payre F, Stern DL. Morphological evolution
caused by many subtle-effect substitutions in regulatory DNA. Nature. 2011; 474:598–603.
[PubMed: 21720363]
Friedberg, EC. DNA repair and mutagenesis. 2. Washington, D.C: ASM Press; 2006.
Gibbs PE, McDonald J, Woodgate R, Lawrence CW. The relative roles in vivo of Saccharomyces
cerevisiae Pol eta, Pol zeta, Rev1 protein and Pol32 in the bypass and mutation induction of an
Roberts et al. Page 12













abasic site, T-T (6–4) photoadduct and T-T cis-syn cyclobutane dimer. Genetics. 2005; 169:575–
582. [PubMed: 15520252]
Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A,
Stevens C, et al. Patterns of somatic mutation in human cancer genomes. Nature. 2007; 446:153–
158. [PubMed: 17344846]
Harfe BD, Jinks-Robertson S. DNA polymerase zeta introduces multiple mutations when bypassing
spontaneous DNA damage in Saccharomyces cerevisiae. Mol Cell. 2000; 6:1491–1499. [PubMed:
11163221]
Harris RS, Liddament MT. Retroviral restriction by APOBEC proteins. Nat Rev Immunol. 2004;
4:868–877. [PubMed: 15516966]
Henry M, Guetard D, Suspene R, Rusniok C, Wain-Hobson S, Vartanian JP. Genetic editing of HBV
DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of
APOBEC3G. PLoS One. 2009; 4:e4277. [PubMed: 19169351]
Hicks WM, Kim M, Haber JE. Increased mutagenesis and unique mutation signature associated with
mitotic gene conversion. Science. 2010; 329:82–85. [PubMed: 20595613]
Jin YH, Clark AB, Slebos RJ, Al-Refai H, Taylor JA, Kunkel TA, Resnick MA, Gordenin DA.
Cadmium is a mutagen that acts by inhibiting mismatch repair. Nat Genet. 2003; 34:326–329.
[PubMed: 12796780]
Katou Y, Kanoh Y, Bando M, Noguchi H, Tanaka H, Ashikari T, Sugimoto K, Shirahige K. S-phase
checkpoint proteins Tof1 and Mrc1 form a stable replication-pausing complex. Nature. 2003;
424:1078–1083. [PubMed: 12944972]
Livingstone-Zatchej M, Marcionelli R, Moller K, de Pril R, Thoma F. Repair of UV lesions in silenced
chromatin provides in vivo evidence for a compact chromatin structure. J Biol Chem. 2003;
278:37471–37479. [PubMed: 12882973]
Llorente B, Smith CE, Symington LS. Break-induced replication: what is it and what is it for? Cell
Cycle. 2008; 7:859–864. [PubMed: 18414031]
Lopes M, Foiani M, Sogo JM. Multiple mechanisms control chromosome integrity after replication
fork uncoupling and restart at irreparable UV lesions. Mol Cell. 2006; 21:15–27. [PubMed:
16387650]
Ma W, Resnick MA, Gordenin DA. Apn1 and Apn2 endonucleases prevent accumulation of repair-
associated DNA breaks in budding yeast as revealed by direct chromosomal analysis. Nucleic
Acids Res. 2008; 36:1836–1846. [PubMed: 18267974]
Mimitou EP, Symington LS. DNA end resection--unraveling the tail. DNA repair. 2011; 10:344–348.
[PubMed: 21227759]
Ponder RG, Fonville NC, Rosenberg SM. A switch from high-fidelity to error-prone DNA double-
strand break repair underlies stress-induced mutation. Mol Cell. 2005; 19:791–804. [PubMed:
16168374]
Rochette PJ, Brash DE. Human telomeres are hypersensitive to UV-induced DNA Damage and
refractory to repair. PLoS Genet. 2010; 6:e1000926. [PubMed: 20442874]
Rogozin IB, Kolchanov NA. Somatic hypermutagenesis in immunoglobulin genes. II. Influence of
neighbouring base sequences on mutagenesis. Biochim Biophys Acta. 1992; 1171:11–18.
[PubMed: 1420357]
Rogozin IB, Pavlov YI, Bebenek K, Matsuda T, Kunkel TA. Somatic mutation hotspots correlate with
DNA polymerase eta error spectrum. Nat Immunol. 2001; 2:530–536. [PubMed: 11376340]
Sakamoto AN, Stone JE, Kissling GE, McCulloch SD, Pavlov YI, Kunkel TA. Mutator alleles of yeast
DNA polymerase zeta. DNA Repair (Amst). 2007; 6:1829–1838. [PubMed: 17715002]
Simonelli V, Narciso L, Dogliotti E, Fortini P. Base excision repair intermediates are mutagenic in
mammalian cells. Nucleic Acids Res. 2005; 33:4404–4411. [PubMed: 16077026]
Smith JM. Natural selection and the concept of a protein space. Nature. 1970; 225:563–564. [PubMed:
5411867]
Stephens P, Edkins S, Davies H, Greenman C, Cox C, Hunter C, Bignell G, Teague J, Smith R,
Stevens C, et al. A screen of the complete protein kinase gene family identifies diverse patterns of
somatic mutations in human breast cancer. Nat Genet. 2005; 37:590–592. [PubMed: 15908952]
Roberts et al. Page 13













Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence
MS, Sougnez C, McKenna A, et al. The mutational landscape of head and neck squamous cell
carcinoma. Science. 2011; 333:1157–1160. [PubMed: 21798893]
Strathern JN, Shafer BK, McGill CB. DNA synthesis errors associated with double-strand-break
repair. Genetics. 1995; 140:965–972. [PubMed: 7672595]
Stratton MR. Exploring the genomes of cancer cells: progress and promise. Science. 2011; 331:1553–
1558. [PubMed: 21436442]
Swartz MN, Trautner TA, Kornberg A. Enzymatic synthesis of deoxyribonucleic acid. XI. Further
studies on nearest neighbor base sequences in deoxyribonucleic acids. J Biol Chem. 1962;
237:1961–1967. [PubMed: 13918810]
Thielen BK, McNevin JP, McElrath MJ, Hunt BV, Klein KC, Lingappa JR. Innate immune signaling
induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through
expression of APOBEC3A isoforms. J Biol Chem. 2010; 285:27753–27766. [PubMed: 20615867]
Valencia-Burton M, Oki M, Johnson J, Seier TA, Kamakaka R, Haber JE. Different mating-type-
regulated genes affect the DNA repair defects of Saccharomyces RAD51, RAD52 and RAD55
mutants. Genetics. 2006; 174:41–55. [PubMed: 16782999]
Wang J, Gonzalez KD, Scaringe WA, Tsai K, Liu N, Gu D, Li W, Hill KA, Sommer SS. Evidence for
mutation showers. Proc Natl Acad Sci U S A. 2007; 104:8403–8408. [PubMed: 17485671]
Westmoreland J, Ma W, Yan Y, Van Hulle K, Malkova A, Resnick MA. RAD50 is required for
efficient initiation of resection and recombinational repair at random, gamma-induced double-
strand break ends. PLoS Genet. 2009; 5:e1000656. [PubMed: 19763170]
Yamanaka S, Balestra ME, Ferrell LD, Fan J, Arnold KS, Taylor S, Taylor JM, Innerarity TL.
Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in
transgenic animals. Proc Natl Acad Sci U S A. 1995; 92:8483–8487. [PubMed: 7667315]
Yang Y, Gordenin DA, Resnick MA. A single-strand specific lesion drives MMS-induced hyper-
mutability at a double-strand break in yeast. DNA repair. 2010; 9:914–921. [PubMed: 20663718]
Yang Y, Sterling J, Storici F, Resnick MA, Gordenin DA. Hypermutability of damaged single-strand
DNA formed at double-strand breaks and uncapped telomeres in yeast Saccharomyces cerevisiae.
PLoS Genet. 2008; 4:e1000264. [PubMed: 19023402]
Roberts et al. Page 14














• Clusters of simultaneous multiple mutations occur in yeast and human genomes
• Mutation clusters can occur in damaged ssDNA during DSB repair or
replication
• Clusters of coordinated C or G mutations in cancers colocalize with
rearrangements
• Clustered mutations in cancers occur at motifs of cytosine deamination by
APOBECs
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Multiple Mutation Reporters. Presented are yeast strains with URA3 (blue) and CAN1
(orange) separated by either 0.9 kb inserted into LYS2 (adjacent reporters) to the left (A) or
right (B) of ARS216 (red) on chromosome II or by 83 kb on the left arm of chromosome V
(separated reporters; C). Isolates that were mutant in both genes were selected by resistance
to the drugs 5-FOA and canavanine.
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Selection and Characterization of Mutation Clusters. FOA-CAN mutation frequencies for
wild type haploid (1n) and diploid (2n) yeast carrying the adjacent (Adj) or separated (Sep)
URA3-CAN1 reporters (see Figure 1 reporters A and C). Selected isolates were sequenced.
(A) The median number of colonies/plate. Error bars indicate 95% confidence intervals (CI).
“ALL” represents colonies from MAT a/α, α/α, and a/a combined. LOH adjusted values are
indicated (see also Table S2, Supplemental text). (B) An example FOA-CAN resistant
genome (named Cra3): gray bars represent each of the 16 yeast chromosomes, the red line
indicates the location of URA3 and CAN1, and blue lines denote the position of mutations.
A segment of chromosome II containing a mutation cluster is enlarged. Cluster lengths (C),
the number of mutations per cluster (D), and Cluster P-values (E) of all sequenced
chromosome II clusters arising from cells treated with 2 (white circles) or 4 mM (gray
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circles) are presented. Black circles indicate unselected clusters. Solid lines indicate median
values.
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MMS-induced Mutated Base Pairs. The total mutated A:T and C:G base pairs in FOA-CAN
dually resistant wild type haploid and diploid yeast carrying the URA3-CAN1 reporter
selected after 2 day exposure to 2 or 4 mM MMS were divided based upon whether they
were clustered (C) or scattered (S). “N” indicates scattered mutations for isolates where no
FOA-CAN selection was applied. Mutations in URA3 and CAN1 as well as annotated
repeat regions including LTRs and retrotransposons were excluded from totals. P-values
were determined with two-sided Fisher’s Exact Test (see also Figure S2).
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Strand-Coordination of Clustered Mutations. Each line (numbers represent the Dataset
Cluster ID from Table S4B) depicts the mutated cytosines (red circles) and guanines (green
circles) in the sequenced strand of a FOA-CAN selected cluster containing more than 3
guanines and/or cytosines originating from the indicated wild type strains carrying the
adjacent URA3-CAN1 reporter treated with either 2 or 4 mM MMS. Only mutations at C
and G bases are depicted. The complete mutation data, including the mutations at A and T
bases, is presented in Figure S1 and Table S4B. Clusters are separated into two categories
(A) non-switching clusters and (B) switching clusters. A coordination switch is defined as 2
or more consecutive coordinated mutations followed by at least 2 consecutive coordinated
mutations of the opposite base. Approximate break points are indicated by arrows. Within
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categories, clusters are sorted by genotype, MMS treatment and finally by cluster length.
Clusters labeled with Dataset Cluster IDs 131,148 and 152 are presented as a subpanel
within (A) since they require a significantly different scale than the remaining non-switching
clusters. (C) Model of MMS induced clusters caused by N3-methyl cytosine adducts in the
single-strand overhangs of resected DSBs.
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Replication-Associated Clusters. (A) Possible causes of ssDNA at dysfunctional forks.
Breakage of the leading strand template would produce a similar outcome as breakage of the
lagging strand template and thus is omitted for simplicity. Expected biases of mutated
cytosines (red circles) and/or guanines (green circles) in the sequenced strand depend on
their location relative to the replication origin. (B) FOA-CAN mutation frequencies induced
with 2 mM MMS. Error bars indicate 95% CI. (C) The URA3 and CAN1 open reading
frames of selected clones from (B) were PCR amplified and Sanger sequenced. Isolates
containing G-G or C-C strand coordinated mutations were tabulated. P-values were
calculated by 2-tailed g test for goodness-of-fit to an expected 1:1 ratio.
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Mutation Clusters in Sequenced Human Cancers. (A) Mutation clusters in non-SHM regions
separated by type of strand-coordination (“A- or T-” coordinated, “G- or C-” coordinated,
and “non-” coordinated). White bars indicate the number of clusters co-localized with
breakpoint(s). Co-localization was registered when the region covered by the cluster plus
left and right flanks of 20,000 nucleotides contained at least one breakpoint. Black bars
depict the number of clusters not associated with a specific breakpoint. (B) Number of
mutations from the coordination classes in (A) that occurred within specific sequence
motifs. Numbers above bars indicate the fold enrichment of clustered mutations occurring at
a motif over the frequency of the motif occurs in the chromosomal sequence that the cluster
spans (See Cluster Sequence in Table S9). Asterisks demark motifs significantly enriched in
mutation clusters (P-value <0.0001) as determined by Chi-square (See also Figures S3). (C)
Distribution of mutations within 17 C-coordinated clusters with greater than 3 mutations.
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Mutated cytosines are categorized by their presence in a TC motif (pink and white striped
diamonds), TCW motif (red diamonds), or no identified motif (pink circles).
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Genome-wide Prevalence of Mutated Motifs in Sequenced Human Cancers. (A) Median
fold enrichment of genome-wide mutations at various motifs (motifs identified in clusters
plus CpG - CG/CG and the AID target motif – WRC/GYW). Numbers above bars indicate
the fold enrichment of mutations occurring at a motif over the frequency of the motif in a
fraction of sequence representative of the each genome. The enrichments of TC/GA and
TCW/WGA also were compared by Wilcoxon signed rank test. (B) Fraction of total
mutations occurring at the motifs described in (A) for individual sequenced tumors (circles).
The horizontal bar indicates the median value (see also Figure S4).
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